Shandong Sinoglory Health
Shandong Sinoglory Health Food Co., Ltd. manufactures soy proteins in China. The company offers soy protein isolate, concentrate, low-temperature edible soybean meal, soybean oil, and soy dietary fiber products. It also exports its products. The company serves in the United States, the European Union, and Australia. Shandong Sinoglory Health Food Co., Ltd. was founded in 2000 and is based in Liao… Read more
Market Cap & Net Worth: Shandong Sinoglory Health (603182)
Shandong Sinoglory Health (SHG:603182) has a market capitalization of $356.36 Million (CN¥2.61 Billion) as of March 19, 2026. Listed on the SHG stock exchange, this China-based company holds position #15143 globally and #4034 in its home market, demonstrating a 4.54% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shandong Sinoglory Health's stock price CN¥15.89 by its total outstanding shares 164550000 (164.55 Million).
Shandong Sinoglory Health Market Cap History: 2022 to 2026
Shandong Sinoglory Health's market capitalization history from 2022 to 2026. Data shows growth from $380.00 Million to $356.36 Million (2.90% CAGR).
Shandong Sinoglory Health Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shandong Sinoglory Health's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.17x
Shandong Sinoglory Health's market cap is 0.17 times its annual revenue
0.14x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
2.37x
Shandong Sinoglory Health's market cap is 2.37 times its annual earnings
5.51x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $380.00 Million | $1.61 Billion | $114.38 Million | 0.24x | 3.32x |
| 2023 | $319.52 Million | $1.69 Billion | $110.14 Million | 0.19x | 2.90x |
| 2024 | $258.13 Million | $1.49 Billion | $109.14 Million | 0.17x | 2.37x |
Competitor Companies of 603182 by Market Capitalization
Companies near Shandong Sinoglory Health in the global market cap rankings as of March 19, 2026.
Key companies related to Shandong Sinoglory Health by market ranking:
- Nestle SA (PINK:NSRGF): Ranked #54 globally with a market cap of $258.19 Billion USD.
- Nestlé S.A. (SW:NESN): Ranked #69 globally with a market cap of $218.85 Billion USD ( CHF200.39 Billion CHF).
- Danone S.A (OTCQX:GPDNF): Ranked #435 globally with a market cap of $49.73 Billion USD.
- Danone SA (PA:BN): Ranked #465 globally with a market cap of $45.94 Billion USD ( €44.75 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #54 | Nestle SA | PINK:NSRGF | $258.19 Billion | $100.43 |
| #69 | Nestlé S.A. | SW:NESN | $218.85 Billion | CHF77.97 |
| #435 | Danone S.A | OTCQX:GPDNF | $49.73 Billion | $78.67 |
| #465 | Danone SA | PA:BN | $45.94 Billion | €70.78 |
Shandong Sinoglory Health Historical Marketcap From 2022 to 2026
Between 2022 and today, Shandong Sinoglory Health's market cap moved from $380.00 Million to $ 356.36 Million, with a yearly change of 2.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥356.36 Million | +0.44% |
| 2025 | CN¥354.79 Million | +37.45% |
| 2024 | CN¥258.13 Million | -19.21% |
| 2023 | CN¥319.52 Million | -15.92% |
| 2022 | CN¥380.00 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Shandong Sinoglory Health was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $356.36 Million USD |
| MoneyControl | $356.36 Million USD |
| MarketWatch | $356.36 Million USD |
| marketcap.company | $356.36 Million USD |
| Reuters | $356.36 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.